The last decade has seen important changes in the treatment of patients with Cushing's syndrome and in this issue (p 262) Fahlbusch et al., from the Federal Republic of Germany, report on their extensive experience of transsphenoidal surgery for Cushing's disease. Cushing's syndrome results from a pathological increase of circulating cortisol, which may be due to an adrenal tumour or secondary to an increase of circulating adrenocorticotrophic hormone (ACTH) and associated with bilateral adrenal hyperplasia. The ACTH usually comes from a pituitary microadenoma, in which case it may be called Cushing's disease', or there may be an ectopic source of the ACTHmost commonly a bronchial carcinoma, less frequently a small pulmonary carcinoid tumour. Occasionally there is an ectopic source of corticotrophin-releasing factor (CRF), in which case the ACTH will come from the pituitary2.
The diagnosis of Cushing's syndrome may be easy but will still need biochemical confirmationor difficult in obese, middle-aged, red-faced, hirsute women with benign essential hypertension. Florid examples of iatrogenic Cushing's syndrome were commonly seen when pharmacological doses of steroids were first used for non-endocrine disease. With increasing use of alternate-day therapy and steroidsparing drugs, these are becoming rare. However, occasional cases are still reported from the use of steroid creams on the skin3'4 and steroid-containing nasal sprays5. Another source of confusion is the 'pseudo-Cushing's syndrome' of the chronic al-coholic6. The simplest diagnostic tests are morning and evening plasma cortisol measurements, and the overnight dexamethasone suppression test. These may give abnormal results in depressed subjects7 and even from the emotional disturbance of admission to hospital8. A more formal screening procedure involves giving 0.5mg dexamethasone 6-hourly for 48 hours. The patient with Cushing's syndrome should show little reduction of plasma cortisol following this9"-0. Patients with depression may fail to suppress", anomalous results may be obtained in patients taking phenytoin'2 and in rare patients who fail to metabolize dexamethasone normally'3. If the diagnosis is still uncertain, an insulin hypoglycaemia test may be helpful; the patient with Cushing's syndrome has little or no. increase of cortisol or growth hormone despite adequate hypoglycaemia'4.
One situation that may still cause problems is the so-called 'cyclical Cushing's syndrome' in which from time to time the test results are normal'5: the only thing to do is to arrange for a repeat set to be done in a few months time.
Having confirmed that the patient has Cushing's syndrome, it is now necessary to decide what it is due to. Measurement of plasma ACTH is essential. If the condition is due to an adrenal tumour, ACTH will be suppressed. If the patient has a pituitary adenoma -Cushing's diseaseit will usually be in the normal range or a little raised. Such a level is in fact high in relation to the plasma cortisol concentration. Patients with ectopic ACTH syndrome tend to have high levels, but they may be normal. The differentiation of Cushing's disease from the ectopic ACTH syndrome is important if transsphenoidal surgery is contemplated. In addition to ACTH measurements, a high-dose dexamethasone suppression test should be done (2 mg 6-hourly for 48 hours); if there is no reduction of plasma cortisol or the urinary excretion of free cortisol, strong suspicion of an ectopic source of ACTH must arise9. Other stimuli give exaggerated responses in patients with Cushing's disease and usually little response with the ectopic ACTH syndrome: for example, lysine vasopressin infusion14 and a 2-day metyrapone test14.
Recently it has been suggested that CRF gives a brisk response of ACTH and cortisol in Cushing's disease, but no response in the ectopic ACTH syndrome16. However, far more experience will be needed with this test before its power of discrimination can be assessed'7. Selective venous sampling with measurements of ACTH have been suggested, and may help in localizing the source ofthe ACTH'8"9. Computerized tomographic scanning (CAT) of the pituitary may suggest the presence of a microadenoma, but these may occur in normal subjects. It has been suggested that before any operation on the pituitary for Cushing's disease, CAT scans of the lungs and abdomen should be undertaken, and this seems a wise precaution20.
Bilateral adrenalectomy has in the past proved an effective treatment for Cushing's disease, and it did not matter very much if the patient had an ectopic ACTH syndrome due to a small undetected pulmonary carcinoid. The disadvantage, apart from the need for replacement therapy, was the growth of pituitary tumours and skin pigmentation -Nelson's syndromein the years following the operation21. Figures for the incidence of Nelson's syndrome vary, but it is certainly high enough to seek an alternative method of treatment22'23. A direct approach to the pituitary seems logical provided an ectopic source of ACTH can be excluded. Pituitary irradiation has been used for many years either by conventional24, interstitial25, a-particle26 or heavy particle27 techniques. The last three are only available in a few centres, and the response to conventional irradiation is at best slow. With the technical improvements in transsphenoidal surgery of the pituitary, it is not surprising that this is now being used in patients with Cushing's disease. As Fahlbusch and colleagues point out in their paper, the small size of many of these ACTH-producing microadenomas makes it a particularly difficult operation. However, good results are reported in their paper and in reports from Montreal28 and San Francisco29.
There is one surprising omission from the paper by 0141-0768/86/ 050253-02/$02.00/0 © 1986 The Royal Society of Medicine Fahlbusch et al., who report 2 postoperative deaths, 4 patients with phlebothrombosis and pulmonary embolism and 3 with meningitis: they state that their unit never refused to operate on a patient, regardless of the severity of his disease. In the UK if the patient has severe Cushing's disease, it is usual to control the worst features of the metabolic derangement with metyrapone before surgery is undertaken30.
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Sunscreens
Normal skin may become burnt, aged or cancerous after sunlight exposure, cutaneous molecular absorption of ultraviolet radiation (UVR) initiating a chain of events leading to these changes. Abnormal skin reactions to sunlight in photosensitivity diseases also frequently occur. Growing awareness of these effects has led in recent years to the search for effective and acceptable UVR-screening preparations to minimize such damage. 
